Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0201-2022Class II

Clinician Programmer Application (CPA) model A610 Clinician Software Application

Medtronic Neuromodulation / initiated 2021-09-23 / Open, Classified / root cause: software

Medtronic Neuromodulation began a recall of Clinician Programmer Application (CPA) model A610 Clinician Software Application on . FDA classified it as Class II and gives the reason as "A software anomaly may occur with the clinician programmer application". As of , the recall status on record is Open, Classified, and MDM tags the root cause as software.

Recall record

Recall number
Z-0201-2022
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Medtronic Neuromodulation
Product
Clinician Programmer Application (CPA) model A610 Clinician Software Application
Product code
MHY Stimulator, Electrical, Implanted, For Parkinsonian Tremor
Reason for recall
A software anomaly may occur with the clinician programmer application.
Root cause tag
software
FDA root cause
Software design
Action
A customer letter was distributed to impacted customers beginning September 16, 2021. Customers are asked to contact their Medtronic representative or Medtronic Technical Services at 1-800-707-0933 to troubleshoot should they experience the software anomaly issue.
Quantity in commerce
3302
Distribution
Worldwide distribution - US Nationwide distribution and the countries of Australia, New Zealand, Canada, Europe, India, Japan, Korea, Middle East, Latin America, Africa, SE Asia and China.
Product codes and lots
Clinician Programmer Application (CPA) model A610 version 3.0.1048, 3.0.1057, 3.0.1062, and 3.0.1081

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0201-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0201-2022Class IIOngoingVoluntary: Firm initiated